Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-20

Clinical Trial Update: Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating human albumin for ascites in patients with liver cirrhosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Albumin

Snippet

Sponsor: University of Bologna | Conditions: Liver Cirrhosis, Ascites | Phase 4 | Status: COMPLETED